Evaluation of a Day Hospital Program for Adolescents and Young Adults With Eating Disorders

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-22
SponsorFondation Santé des Étudiants de France

About this trial

This study aims to evaluate the clinical, psychological, and functional outcomes of adolescents with anorexia nervosa receiving multidisciplinary care in hospital settings. Participants are treated either in a day hospitalization program or in a full-time inpatient program, in accordance with the French national guidelines (Haute Autorité de Santé, HAS) for the management of anorexia nervosa.

The study seeks to better understand the evolution of patients' health status over time, including nutritional, psychological, and social dimensions, and to identify factors associated with treatment response. Data will be collected as part of routine clinical care without modification of the standard therapeutic management.

The results of this study may help improve clinical practices and optimize care pathways for adolescents with anorexia nervosa.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adolescents and young adults aged 12 to 22 years

Diagnosed with an eating disorder

Referred for admission to the day hospital program between October 2019 and December 2023

Provided informed consent (and parental consent for minors)

Disqualifiers

Refusal to participate

Age below 12 years or above 22 years

Trial design

Design model

Parallel

Treatments tested in this trial

  • Day Hospital Multidisciplinary Care

    Other intervention

    Participants admitted to the day hospital receive a multidisciplinary treatment program including psychiatric, medical, nutritional, and psychosocial care, delivered through structured daytime sessions without overnight stay.

  • Standard Care Outside Day Hospital Program

    Other intervention

    Participants not admitted to the day hospital program receive usual care according to standard clinical pathways outside the specialized day hospital setting.

Treatment groups

307 Participants
are divided into 2 treatment groups
Group A: Day Hospital ProgramOther 1 intervention
Group B: Non-Admitted ParticipantsOther 1 intervention

Trial outcomes

Primary outcomes

1

Change in Body Mass Index (BMI)

Time frame
From admission request to at least 18 months follow-up

Secondary outcomes

1

Change in eating disorder psychopathology assessed by EDE-Q

Eating disorder psychopathology will be assessed using the Eating Disorder Examination Questionnaire (EDE-Q), a self-report scale ranging from 0 to 6, with higher scores indicating more severe symptoms. The assessment will be performed at admission and discharge.

Time frame
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
2

Change in body image concerns assessed by BSQ

Body image concerns will be assessed using the Body Shape Questionnaire (BSQ), a self-report scale with higher scores indicating greater body dissatisfaction. The assessment will be performed at admission and discharge.

Time frame
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
3

Change in anxiety and depression symptoms assessed by HADS

Anxiety and depression symptoms will be assessed using the Hospital Anxiety and Depression Scale (HADS), which includes subscales for anxiety and depression, each ranging from 0 to 21, with higher scores indicating greater symptom severity. The assessment will be performed at admission and discharge.

Time frame
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
4

Change in obsessive-compulsive symptoms assessed by MOCI

Obsessive-compulsive symptoms will be assessed using the Maudsley Obsessive-Compulsive Inventory (MOCI), where higher scores indicate more severe symptoms. The assessment will be performed at admission and discharge.

Time frame
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: